CB2 Insights Acquires Multi-Location Medical Cannabis Clinic Group, Relaxed Clarity

NEXT STORY
Global cephalosporin market to reach $14.02 billion by 2025: AMR
PREV STORY
Paratek Pharmaceuticals Presenting New Data from NUZYRA™ (Omadacycline) Development Program at ECCMID 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2018 Financial Results

Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday ...

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals, in Collaboration with Atlantic Health System, Announces Initiation of a Phase I Study of CPI-613 in Combination with Gemcitabine and Nab-Paclitaxel for Patients with Locally Advanced or Metastatic Pancreatic Cancer

Newark, NJ, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a clinical stage ...

author_avatar
NASDAQ Market News

Novartis presents first-of-its-kind histology data with iscalimab (CFZ533) suggesting the extended survival of transplanted organs may be possible

author_avatar
NASDAQ Market News